Find your next paid study

Wake Forest University Health SciencesNCT06412029

Actual pay is set by the research site.

Phase 3

A 52-week Multi-center, Randomized, Double-blind, Placebo Controlled Phase 3 Study to Evaluate the Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)

The purpose of this phase 3 study is to establish the efficacy, safety and tolerability of remibrutinib in adult participants with severe chronic pruritus of u…

Chronic Pruritus of Unknown Origin

Novartis PharmaceuticalsNCT07700056

~$50 – $2,100

Actual pay is set by the research site.

Phase 1

CATALINA-4: Phase 1B/2 Study of TORL-1-23 With Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Newly Diagnosed Patients With Advanced Stage Ovarian Cancer

A Phase 1B/2 Study to Investigate the Safety and Efficacy of TORL-1-23 with Chemotherapy Given Before Initial Surgery in Women with Advanced Stage Ovarian Canc…

FIGO Stage III and IV Ovarian CancerFallopian Tube CancersPrimary Peritoneal Cancer

TORL Biotherapeutics, LLCNCT07322094

~$150 – $4,200

Actual pay is set by the research site.

PregnancyPost PartumDoula Care+6 more

Deconstructing Maternal Burdens: Doulas and the Community Unite for Health

This study is a randomized controlled trial comparing two models of doula support for pregnant individuals enrolled in Medicaid: an enhanced doula support mode…

University of FloridaNCT07799805

Actual pay is set by the research site.

Major Depressive Disorder

Optimized Methods for Measuring Brain Excitability in Depression

The goal of this study is to improve depression treatment by establishing reliable prefrontal excitability markers through Targeting with Automated Real-time G…

Stanford UniversityNCT07242105

Actual pay is set by the research site.

The Feasibility of Prolacta CR for Treatment of Neonatal Hypoglycemia

Prolact CR (cream) is a fat supplement that is derived from pasteurized human donor milk. It has been utilized in babies who are born premature in the neonatal…

Neonatal Hypoglycemia

Baylor Research InstituteNCT07217483

~$10 – $1,125

Actual pay is set by the research site.

Oncologic Complications and Emergencies

Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths

To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.

M.D. Anderson Cancer CenterNCT06217783

Actual pay is set by the research site.

Phase 2

An Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer

This study is being done to answer the following question: What are the effects of a new drug or drugs on ovarian cancer? The pre-study screening may be done t…

Ovarian Cancer

Canadian Cancer Trials GroupNCT04918186

~$75 – $3,000

Actual pay is set by the research site.

StrokeOccupational TherapyActivities of Daily Living+2 more

Virtual Activities of Living for Occupational Rehabilitation (VALOR)

Duke University will serve as the clinical research site for the Phase II RCT of the VALOR system, which enables telehealth delivery of evidence-based upper ex…

Barron Associates, Inc.NCT07450586

~$10 – $1,050

Actual pay is set by the research site.

Bilateral Cochlear ImplantsHearing Loss, BilateralHealthy

How Spatial Cues Support Communication: Interactions Between Auditory Spatial Features and Task Demands Across Cortical Networks

Understanding speech in restaurants and other noisy environments is the most common complaint from the more than 60 million Americans with hearing impairment. …

University of South FloridaNCT07765186

Actual pay is set by the research site.

Utilization of a 3D Printed Mechanical Balancer During Total Knee Arthroplasty (TKA)

The aim of this study is to test a 3D-printed mechanical balancer in a clinical setting during surgery to further evaluate the utility of the device. This will…

Total Knee Arthroplasty

NYU Langone HealthNCT06654661

~$10 – $1,125

Actual pay is set by the research site.

Phase 1

A Phase 1, First-in-Human Study of MEN2501, a KIF18A Inhibitor, as Monotherapy in Participants With Platinum-Resistant Ovarian Cancer

This is a first-in-human, open-label, dose-escalation, dose-optimization trial designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamic…

Platinum-resistant Ovarian Cancer